Early Data Show Promise for Galinpepimut-S and Opdivo in Mesothelioma Patients
A combination of the immunotherapy drugs galinpepimut-S and Opdivo may give mesothelioma patients a few extra months, according to newly-released…
Emerging treatments & clinical trials based on how immune systems affect the development of mesothelioma cell types. Get up to date analysis.